IFNA1 and systemic lupus erythematosus: In addition, the decrease in autoantibodies by the treatment would also contribute to disrupting a positive feed-forward loop of autoantibody-immune complex-mediated IFN production in pDCs via endosomal nucleic acid-sensing Toll-like receptors in SLE [46].